Nanding, Abdulrahman .
HRN: 15-57-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/28/2023
09/04/2023
IV
600mg
Q8H
Scrotal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes